"HIV-1" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte.
MeSH Number(s)
B04.820.650.589.650.350.400
B04.909.777.731.589.650.350.400
Concept/Terms
HIV-1- HIV-1
- Immunodeficiency Virus Type 1, Human
- Human Immunodeficiency Virus Type 1
- HIV-I
- Human immunodeficiency virus 1
Below are MeSH descriptors whose meaning is more general than "HIV-1".
Below are MeSH descriptors whose meaning is more specific than "HIV-1".
This graph shows the total number of publications written about "HIV-1" by people in Harvard Catalyst Profiles by year, and whether "HIV-1" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 82 | 9 | 91 |
1995 | 78 | 6 | 84 |
1996 | 103 | 4 | 107 |
1997 | 110 | 10 | 120 |
1998 | 129 | 9 | 138 |
1999 | 130 | 9 | 139 |
2000 | 128 | 22 | 150 |
2001 | 101 | 32 | 133 |
2002 | 108 | 19 | 127 |
2003 | 108 | 22 | 130 |
2004 | 112 | 20 | 132 |
2005 | 126 | 17 | 143 |
2006 | 129 | 32 | 161 |
2007 | 127 | 22 | 149 |
2008 | 121 | 36 | 157 |
2009 | 136 | 33 | 169 |
2010 | 159 | 33 | 192 |
2011 | 133 | 41 | 174 |
2012 | 168 | 38 | 206 |
2013 | 163 | 32 | 195 |
2014 | 145 | 34 | 179 |
2015 | 130 | 27 | 157 |
2016 | 116 | 25 | 141 |
2017 | 92 | 43 | 135 |
2018 | 112 | 28 | 140 |
2019 | 88 | 43 | 131 |
2020 | 105 | 43 | 148 |
2021 | 99 | 25 | 124 |
2022 | 100 | 7 | 107 |
2023 | 67 | 1 | 68 |
2024 | 9 | 0 | 9 |
Below are the most recent publications written about "HIV-1" by people in Profiles.
-
Preclinical toxicity analyses of lentiviral vectors expressing the HIV-1 LTR-specific designer-recombinase Brec1. PLoS One. 2024; 19(3):e0298542.
-
Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-a2a. Cell. 2024 Feb 29; 187(5):1238-1254.e14.
-
HIV-1 Proviral Genome Engineering with CRISPR-Cas9 for Mechanistic Studies. Viruses. 2024 Feb 13; 16(2).
-
Proliferation of HIV-1 reservoir cells: The delusion of infinite growth. J Exp Med. 2024 Mar 04; 221(3).
-
Development of a highly sensitive and specific intact proviral DNA assay for HIV-1 subtype B and C. Virol J. 2024 Jan 31; 21(1):36.
-
Inhibition of human immunodeficiency virus (HIV-1) infectivity by expression of poorly or broadly neutralizing antibodies against Env in virus-producing cells. J Virol. 2024 Feb 20; 98(2):e0159423.
-
IL-15 reprogramming compensates for NK cell mitochondrial dysfunction in HIV-1 infection. JCI Insight. 2024 Jan 16; 9(4).
-
Functional Analysis of KAP1/TRIM28 Requirements for HIV-1 Transcription Activation. Viruses. 2024 Jan 13; 16(1).
-
Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques. Cell. 2024 01 04; 187(1):79-94.e24.
-
Prophylactic HIV-1 vaccine trials: past, present, and future. Lancet HIV. 2024 Feb; 11(2):e117-e124.